Â鶹ÊÓƵ

Global Trehalose Market Trends and Insights

Rising Health Consciousness Boosts Demand for Natural Sugar Alternatives in Functional Foods and Beverages

Consumers are paying closer attention to ingredient labels, preferring familiar names. This behavioral change positions trehalose, a sugar naturally present in mushrooms, honey, and yeast, as a preferred alternative to synthetic humectants. This distinction is more significant than caloric equivalence. Although both trehalose and sucrose provide 4 kilocalories per gram, formulators market trehalose as a "functional sugar" due to its potential to support cellular stress responses, a claim supported by peer-reviewed autophagy research. The European Food Safety Authority's updated 2024 guidance emphasizes that novel-food applications must demonstrate safety at proposed usage levels^{[1]Source: European Food Safety Authority, "Navigating Novel Foods: what EFSA’s updated guidance means for safety assessments", efsa.europa.eu}. As a result, manufacturers are required to conduct 90-day feeding studies, even though trehalose has been consumed in Japan for decades and is recognized by the EFSA. Beverage developers leverage trehalose's low hygroscopicity to prevent clumping in powdered drink mixes, reducing production rejects and extending warehouse shelf life. Functional-food brands targeting metabolic health are incorporating trehalose into protein bars and meal replacements, relying on its slower glucose release compared to maltodextrin, despite mixed clinical evidence regarding its glycemic-index benefits. 

Clean-Label Trends in Food Industry Favor Trehalose as a Preservative

Trehalose, a natural sugar, serves a critical function in the food industry. It prevents ice-crystal growth during freeze-thaw cycles and delays starch retrogradation in baked goods. These combined benefits enable formulators to replace synthetic emulsifiers and extend product shelf lives without compromising texture. This approach gained momentum after Cargill's distribution agreement with Nagase Viita in September 2024. The deal not only ensured trehalose supply but also included technical support, such as shelf-life validation protocols, simplifying the reformulation process for mid-tier bakeries. Trehalose's extensive use in Japan, particularly in rice cakes and frozen seafood, provides a regulatory advantage. The Ministry of Health, Labour and Welfare in Japan classifies trehalose as both a Designated and Existing Food Additive, streamlining import approvals for Asian-manufactured confections targeting North American retail markets^{[2]Source: Ministry of Health, Labour and Welfare, "Food Additives", mhlw.go.jp}. Furthermore, frozen-dough manufacturers value trehalose for its ability to preserve yeast viability through repeated freeze-thaw cycles, reducing waste in just-in-time bakery operations. The 0.9 percentage-point CAGR impact is most notable in North America and Europe. In these regions, clean-label claims can achieve a 10% to 15% price premium, and retailers are increasingly requiring ingredient simplification for shelf placement.

Growth in Cosmetics for Moisturizing and Skin-Protective Benefits

Trehalose, recognized for its ability to bind water molecules in a glassy matrix, has become a preferred humectant in leave-on serums and eye creams. This is particularly true for brands targeting dry-climate markets or offering post-procedure skincare solutions. Dermatology journals emphasize trehalose's critical role in stabilizing cell membranes under desiccation stress. Cosmetic chemists leverage this property to reduce transepidermal water loss, delivering results without the sticky after-feel commonly associated with glycerin or propylene glycol. The Asia Pacific region, led by Japan and Korea, has pioneered trehalose adoption. Since the early 2000s, formulators in these countries have incorporated trehalose into essence toners and sheet masks. As K-beauty brands expand into Sephora and Ulta, this expertise is now influencing Western markets. Trehalose's compatibility with peptides and retinoids—without causing metal chelation or active degradation—enables the development of multi-functional formulations. This aligns with the preferences of modern consumers seeking simplified beauty routines. Regulatory challenges are minimal; trehalose is listed on the International Nomenclature of Cosmetic Ingredients (INCI) without concentration limits. Its Generally Recognized As Safe (GRAS) status in food further supports its favorable safety profile for leave-on cosmetic applications.

Pharmaceutical Applications in Drug Delivery, Tablets, and Syrups

Biologic-drug developers face a major challenge: monoclonal antibodies and mRNA vaccines degrade rapidly at room temperature. This creates a dependency on cold-chain logistics, increasing distribution costs and restricting access in low-resource regions. Trehalose provides a solution by forming hydrogen bonds with protein surfaces during lyophilization, which prevents aggregation and preserves the tertiary structure upon reconstitution. A 2025 study published in Pharmaceutics revealed that trehalose-loaded lipid nanoparticles achieved a 17.7% encapsulation efficiency for mRNA payloads, a 40% improvement compared to sucrose controls, and maintained potency after 6 months at 4°C. Nagase Viita markets pharmaceutical-grade Trehalose SG for antibody-drug conjugates, a market segment expected to exceed USD 15 billion by 2030, driven by advancements in oncology pipelines. Tablet manufacturers leverage trehalose's direct-compression properties; it flows smoothly through hoppers and exhibits low friability, reducing the need for binders and disintegrants, which simplifies dissolution profiles. Syrup formulators benefit from trehalose's non-reducing sugar chemistry, which prevents Maillard browning during heat sterilization and extends shelf life in tropical climates.

High Production Costs Compared to Conventional Sugars

Producing trehalose enzymatically demands a costly fermentation setup, unique enzyme strains, and a multi-step purification process to ensure food-grade quality. As a result, production costs soar to 30% to 50% above those of sucrose on a per-kilogram basis. This price gap shrinks only when formulators recognize trehalose's dual benefits: its ability to sweeten and stabilize. However, many bakeries and confectioners, operating on tight margins, struggle to absorb these ingredient premiums without hiking retail prices. Adding to the challenge is the volatility of corn-starch feedstock. For instance, March 2025 futures in China were trading between approximately USD 350 and 355 per metric ton. Such prices can tighten margins, especially for producers without long-term supply contracts. In South America and Southeast Asia, smaller manufacturers often turn back to sucrose or glucose syrups during trehalose price surges, casting doubt on volume predictions. The -0.7 percentage-point CAGR decline highlights the sensitivity of certain segments, especially mid-tier bakeries and beverage co-packers, who lean towards cost considerations over clean-label aspirations.

Stringent Regulations on Novel Food Ingredients

Europe's Novel Food Regulation (EU 2015/2283) requires pre-market safety assessments for ingredients without a significant consumption history before May 1997. Trehalose narrowly meets this threshold due to its use in Japan since the 1990s. However, EFSA's September 2024 update now requires applicants to provide 90-day toxicity studies and allergenicity data, even for substances already classified as Generally Recognized As Safe (GRAS). This update increases approval timelines to 18 months and adds compliance costs of EUR 200,000 to 300,000 per dossier. In emerging markets, additional challenges arise. Brazil's ANVISA and South Africa's Department of Health categorize trehalose as a novel ingredient, requiring case-by-case reviews. This classification delays product launches and disrupts regional supply chains. In China, the GB 2760-2024 standard, finalized in March 2024 and effective February 8, 2025, sets maximum use levels for trehalose. However, enforcement is delegated to provincial bureaus, leading to inconsistent interpretations that complicate national distribution. The resulting -0.4 percentage-point CAGR impact is most significant in Europe and emerging markets, where regulatory uncertainties hinder investments in trehalose-based reformulations.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Form: Powder Dominates, Liquid Gains in Beverages

In 2025, powder trehalose accounted for 61.75% of the market share, primarily due to its compatibility with dry-blend manufacturing processes across confectionery, baking mixes, and pharmaceutical tablet compression. Its extended shelf life—up to three years in moisture-barrier packaging—and ability to flow uniformly through hoppers without bridging make it a preferred choice, reducing downtime in high-speed production lines. Liquid trehalose, projected to grow at a 6.84% CAGR through 2031, is favored by beverage formulators for its suitability with in-line dosing systems, which eliminate dust-handling costs and enhance worker safety. A significant 2024 study on spray-drying techniques demonstrated that liquid trehalose can be atomized directly into carbonated beverages without precipitating, marking a technical breakthrough that extends its applications beyond still beverages. Additionally, cosmetic manufacturers increasingly prefer liquid trehalose for serums and lotions due to its ability to disperse evenly in aqueous phases without requiring high-shear mixing, simplifying formulation and reducing energy consumption during production.

Both forms of trehalose are in demand for pharmaceutical applications, with powder prioritized for lyophilized biologics and liquid for syrup formulations. Nagase Viita's Trehalose SG, a pharmaceutical-grade powder, complies with USP/EP monograph specifications and is validated for use in monoclonal-antibody formulations, a segment that experienced 12% year-over-year growth in 2024 as oncology pipelines advanced. Dietary supplement brands prefer powder for capsules and tablets, leveraging its direct-compression properties to eliminate the need for binders that complicate dissolution profiles. The segmentation between forms is driven by end-use requirements rather than cost differences. Liquid trehalose, which commands a 5% to 10% price premium due to additional processing steps, is still widely adopted by beverage manufacturers who prioritize reduced dust-explosion risks and improved dosing accuracy.

By Application: Food Leads, Pharmaceuticals Accelerate

In 2025, the food and beverage sector accounted for 42.11% of trehalose applications, driven by its multifunctional benefits in frozen dough, confectionery, and ready-to-eat meals. Trehalose prevents ice-crystal growth, masks bitter off-notes, and extends shelf life without synthetic preservatives. Japanese and Korean manufacturers have used trehalose in rice cakes, frozen seafood, and instant noodles since the 1990s, easing regulatory approvals in export markets. The pharmaceutical sector is projected to grow at a 6.69% CAGR through 2031, supported by biologics manufacturing and studies validating trehalose's role in cold-chain-free mRNA vaccine formulations.

Trehalose's humectant properties are widely used in cosmetics and personal care, including eye creams, sheet masks, and skincare targeting desiccation stress. Asia Pacific formulators, particularly Japanese and Korean brands, lead adoption by incorporating trehalose into essence toners at concentrations up to 5%, offering hydration without a sticky residue. The "Others" category includes animal feed, where trehalose reduces heat stress in dairy cattle, and industrial biotechnology, where it stabilizes enzymes during storage. Meihua Holdings' 2024 report noted RMB 7.945 billion (USD 1.1 billion) in revenue from trehalose-related products, though this marked a 19.19% decline due to raw material costs and erythritol competition.

Geography Analysis

In 2025, North America held 38.28% of the market share, supported by the FDA's GRAS status (GRN 45, granted in 2000) and Cargill's exclusive distribution of Nagase Viita's TREHA brand in the U.S. and Europe. This partnership streamlined supply chains and accelerated ingredient trials for Tier-1 food conglomerates. The region's biologics manufacturing base, concentrated in Massachusetts, New Jersey, and California, uses trehalose as a lyophilization excipient to prevent protein aggregation. Clean-label trends in bakery and confectionery, along with pharmaceutical applications like mRNA vaccines, are expected to sustain mid-single-digit growth through 2031.

Asia Pacific is projected to grow at 7.92% CAGR through 2031, driven by China's synthetic-biology scale and Japan's regulatory precedent for exports. Meihua Holdings, with 2024 revenue of RMB 25.069 billion (USD 3.5 billion), achieves unmatched economies of scale by producing trehalose alongside amino acids and nucleotides. China's GB 2760-2024, effective February 2025, removes regulatory hurdles by codifying use levels and purity standards. In Japan and South Korea, trehalose is widely used in cosmetics, and K-beauty expansion into Southeast Asia is expected to boost demand further. According to the Ministry of Food and Drug Safety data from 2023, production value of cosmetics in South Korea was USD 11 billion.

Europe's growth depends on Novel Food compliance, with the EU requiring trehalose to be labeled as "a source of glucose," complicating marketing to low-glycemic consumers. EFSA's 2024 guidance adds 90-day toxicity studies for GRAS-approved substances, increasing approval timelines and costs. Germany and France lead in bakery and frozen food applications, where trehalose prevents starch retrogradation and extends shelf life. Pharmaceutical demand is modest but expected to grow as biosimilars requiring lyophilization excipients gain EMA approval. South America and the Middle East & Africa hold smaller market shares but show potential in niche applications. Brazil's health-and-wellness sector and South Africa's pharmaceutical manufacturing hubs are driving incremental growth. However, regulatory fragmentation and import tariffs limit short-term expansion. Despite these challenges, the regions are expected to see gradual adoption of trehalose in both food and pharmaceutical sectors.

Regulatory Landscape

Trehalose is regulated primarily as a food additive/ingredient, with jurisdiction-specific pathways grounded in long-standing approvals. In the United States, trehalose has multiple FDA Generally Recognized as Safe (GRAS) notices, including GRN 45 (2000) with an FDA "no questions" response for use in foods in general, while a later notice (GRN 912, 2021) was voluntarily withdrawn by the notifier, highlighting how companies still manage use-level and dossier strategy within the GRAS framework. Internationally, JECFA evaluated trehalose in 2000 and assigned an ADI "not specified", supporting broad food-use positioning when aligned with local labeling and purity requirements.

In the European Union, trehalose is authorized as a novel food ingredient under Commission Decision 2001/721/EC, linking commercialization to the conditions defined in that authorization and to broader novel-food compliance expectations for reformulations. Canada treats trehalose within its novel food framework, listing it as an approved novel food produced via a multi-step enzymatic process from liquefied starch, which anchors documentation requirements around production method and specifications when importing or supplying food manufacturers.

Value Chain Analysis

The trehalose value chain begins with carbohydrate feedstocks (commonly starch from corn or tapioca), followed by enzymatic conversion and multi-step purification to meet food- and pharmaceutical-grade specifications. Producers with proprietary enzymatic processes and integrated operations (for example, Nagase Viita's TREHA platform) convert starch-derived intermediates into trehalose, then complete the conversion through drying (powder) or formulation (liquid) to reach required purity and microbiological limits. For buyers in bakery, beverages, and biologics excipients, purification complexity and the quality system are a key cost and lead-time driver.

Downstream, distribution and application support carry significant weight because trehalose is often sold on formulation performance rather than sweetness alone. Global supply remains concentrated in Asia (notably Japan and China), and Western manufacturers frequently depend on import-linked supply chains and distribution partners to maintain continuity. That concentration raises exposure to logistics disruption and trade-policy or tariff volatility, which leads some buyers to pursue supplier diversification, dual sourcing, and tighter specification alignment across regions to reduce reformulation risk.

Market Opportunities and Future Outlook

The expansion of pharmaceutical-grade trehalose and adjacent low-endotoxin excipient systems for biologics workflows represents a clear whitespace where stability and impurity control are material. Nagase Viita has positioned trehalose within its SOLBIOTE portfolio (including TREHALOSE SG and TREHALOSE 100 PH), and the company also announced a SUCROSE SG launch timeline into mid-2025, indicating continued investment in high-purity excipient offerings that use shared quality infrastructure and customer channels with trehalose.

Process innovation offers another opportunity, focused on lowering conversion and purification costs while maintaining product quality. Academic work has described newer enzymatic routes, including TreS-based biocatalysis using high-sugar tolerant Saccharomyces cerevisiae as whole-cell catalysts, reporting materially higher yields from maltose with fewer problematic by-products. This directly targets a major commercial cost driver for trehalose, namely downstream purification. On the market-access side, established regulatory anchors in the United States (FDA GRAS framework, including GRN 45) and the European Union (Commission Decision 2001/721/EC) continue to support product development and cross-border supply, while Canada’s approved novel food listing for enzymatically produced trehalose provides a defined pathway for importers and brand owners aligning specifications to the stated production method.